Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...

Bristol Myers Squibb (BMS) has secured another win for Opdivo (nivolumab), becoming the only FDA-approved PD-1 inhibitor for resectable non-small cell lung cancer NSCLC in both a neoadjuvant-only ...

The cost of installing a central air conditioning system varies widely depending on your home’s size, the type and efficiency of the unit, and whether ductwork is already in place. Some or all of the ...

Abstract: Electric vehicles (EVs) hold great potential as a sustainable mode of transportation. Nevertheless, issues with their effectiveness and safety still exist, particularly with relation to ...

The impending merger between Bristol-Myers Squibb (BMS) and Medarex marks the end of an era. Medarex is one of the last independent public biotech companies that built their businesses around ...

Abstract: Information and recommendations on the design, configuration, and interoperability of battery management systems in stationary applications is included in this recommended practice. The ...